12/16/2024
8:50 AM | Atea Pharmaceuticals (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SCHEDULE 13D | |
12/12/2024
5:00 PM | Atea Pharmaceuticals (Issuer)
BERGER FRANKLIN M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
4:17 PM | Atea Pharmaceuticals (Subject)
BERGER FRANKLIN M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/19/2024
11:15 PM | Atea Pharmaceuticals (Filer)
| Form EFFECT | |
11/15/2024
9:34 AM | Atea Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
11/07/2024
3:58 PM | Atea Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/07/2024
3:41 PM | Atea Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
|
11/07/2024
3:27 PM | Atea Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
7:02 PM | Atea Pharmaceuticals (Issuer)
Sommadossi Jean-Pierre (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2024
3:22 PM | Atea Pharmaceuticals (Subject)
JPM Partners LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:09 PM | Atea Pharmaceuticals (Subject)
JPM Partners LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/17/2024
3:16 PM | Atea Pharmaceuticals (Subject)
JPM Partners LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
3:45 PM | Atea Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
3:15 PM | Atea Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
4:59 PM | Atea Pharmaceuticals (Issuer)
Polsky Bruce (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
5:00 PM | Atea Pharmaceuticals (Issuer)
Lucidi Bruno (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
5:06 PM | Adams Jerome M. (Reporting)
Atea Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
5:08 PM | Atea Pharmaceuticals (Issuer)
BERGER FRANKLIN M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
5:12 PM | Atea Pharmaceuticals (Issuer)
Duncan Barbara Gayle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:54 PM | Atea Pharmaceuticals (Issuer)
Murphy Polly A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:21 PM | Atea Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
4:32 PM | Atea Pharmaceuticals (Subject)
Polsky Bruce (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2024
5:34 PM | Atea Pharmaceuticals (Issuer)
Sommadossi Jean-Pierre (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:15 PM | Atea Pharmaceuticals (Filer)
| Form DEFA14A | |
05/14/2024
3:43 PM | Atea Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024
3:16 PM | Atea Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
3:21 PM | Atea Pharmaceuticals (Filer)
| Form DEF 14A | |
02/28/2024
3:18 PM | Atea Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
10:35 AM | Atea Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
02/15/2024
8:15 AM | Atea Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
7:02 PM | Atea Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
02/09/2024
7:35 AM | Atea Pharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
02/07/2024
8:14 AM | Atea Pharmaceuticals (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G | |
02/07/2024
8:25 AM | Atea Pharmaceuticals (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G/A | |
02/02/2024
8:26 PM | Atea Pharmaceuticals (Issuer)
Foster Wayne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
8:29 PM | Atea Pharmaceuticals (Issuer)
Horga Maria Arantxa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
8:30 PM | Atea Pharmaceuticals (Issuer)
Sommadossi Jean-Pierre (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
8:31 PM | Atea Pharmaceuticals (Issuer)
Corcoran Andrea (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
8:24 PM | Atea Pharmaceuticals (Issuer)
Hammond Janet MJ (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
8:25 PM | Atea Pharmaceuticals (Issuer)
Vavricka John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
8:46 AM | Atea Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
Genesis leading the smart algo revolution? (Ad) I’m revealing an exciting breakthrough that can help trade the markets unlike anything you’ve ever seen before…
Because with my BRAND NEW smart algo you’ll always have a constant stream of alerts firing off in your back pocket to choose from.
Here’s why:
It does all the heavy lifting for you… automatically.
Stock Ticker, Entry Price, Profit Target, Stop Loss, and even an Individual Chart! You’ll want to see what I’ve put on this page right here |
